Picasa contains Posaconazole, an antifungal medication used to treat and prevent serious fungal infections, especially in people with weakened immune systems, such as those undergoing chemotherapy or stem cell transplants.
| Composition | Posaconazole |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Packing | 105 ml in 1 bottle |
| Prescribed For | Severe Fungal Infections |
| Expiry | December 2027 |
Sutykine 50 mg Capsule is an oral targeted therapy that contains Sunitinib Malate, used in the treatment of advanced cancers such as renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Packing | 70 Capsules |
| Prescribed For | Anticancer |
| Expiry | December 2027 |
Enzamide 40 mg contains enzalutamide, a nonsteroidal androgen receptor inhibitor prescribed primarily for castration-resistant prostate cancer (CRPC)—both metastatic (spread beyond the prostate) and non-metastatic forms.
| Composition | Enzalutamide |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Packing | 56 Capsules |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Daslemia 70 mg is an oral prescription medication that contains dasatinib, a targeted therapy classified as a tyrosine kinase inhibitor (TKI), and it is primarily used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) and Ph+ acute lymphoblastic leukemia (Ph+ ALL).
| Composition | Dasatinib |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Packing | 60 Tablets |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
